Thus, the accumulation of MPO into the coronary vasculature and resultant impairment of NO bioactivity and endothelial function can conceivably contribute to the compromised coronary circulation function and poor myocardial perfusion in MI survivors (Figure 3) [48,62,70,101]. The gene discussed is MPO; the disease is myocardial infarction.